Aspen Park Pharmaceuticals is a privately held company that focuses on developing and commercializing pharmaceutical and consumer health products for men's and women's health, diseases, and oncology. Their product candidates for men include treatments for benign prostatic hyperplasia, male infertility, side effects of hormonal prostate cancer therapies, gout, sexual dysfunction, and prostate cancer. For women, they have product candidates for female sexual health, advanced breast, and ovarian cancers. Their flagship product, PREBOOST, reduces premature ejaculation. The company operates in various regions worldwide, supplying to approximately 150 countries. They have a South African pharmaceutical business that offers prescription generic and ethical pharmaceutical products, over-the-counter products, and active pharmaceutical ingredients. Aspen Park Pharmaceuticals is also focused on developing novel therapies for men's health conditions such as male secondary hypogonadism, prostate cancer, and sexual dysfunction.